Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

U.S. Justice Department to Push Prosecutors on Opioids

Reuters Staff  |  September 18, 2016

WASHINGTON (Reuters)—The U.S. Justice Department will enlist federal prosecutors to help fight the nation’s opioid crisis by sharing information on overprescribing doctors and coordinating with public health officials to address addiction, USA Today reported on Friday.

“You can’t just have an enforcement strategy alone,” Attorney General Loretta Lynch told the newspaper in an interview. She said the department would issue the new plan next week in a memo to its 94 U.S. attorney offices.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Lynch says sharing information about physicians tied to prescription drug abuse could help authorities better identify drug traffickers and the routes they use, the report said, adding that working with local health officials will help give equal attention to prevention and treatment efforts.

“There is no one magic bullet for this,” Lynch told USA Today.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Justice Department representatives could not be immediately reached to confirm the report.

The effort is a final push during the waning months of the Obama administration to address the opioid crisis, which has hit certain states, such as New Hampshire and West Virginia, particularly hard and has surfaced as an issue in the November presidential election.

Overdose deaths tied to opiates have skyrocketed in recent years in a widening epidemic involving growing abuse of heroin, as well as prescription painkillers such as Vicodin, OxyContin and Percocet.

The number of these deaths quadrupled to nearly 28,700 in 2014 from 2000, according to U.S. Centers for Disease Control and Prevention data.

Efforts to turn the tide have fallen short, pressuring local law enforcement and policymakers at every level to find a solution.

Democrats in Congress have been pushing for money to implement legislation passed earlier this year to fight heroin addiction, making it a topic of negotiation, though not a main issue, in efforts to keep the government running after Sept. 30.

President Barack Obama earlier this year pledged to expand treatment for people addicted to such drugs, offering states more money to treat addition and make available the overdose antidote called naloxone.

In July, Obama signed a bipartisan measure into law aimed at protecting drug-dependent newborns and assisting their parents.

U.S. health regulators in recent weeks also strengthened warnings about opioids as part of their broader plan to reduce the number of deaths from abuse of these drugs, calling it a public health crisis.

Democratic presidential nominee Hillary Clinton has outlined her plan to tackle addiction, while her Republican rival, Donald Trump, has also highlighted the issue on the campaign trail.

Page: 1 2 | Single Page
Share: 

Filed under:AnalgesicsDrug Updates Tagged with:Department of JusticeOpioidsOverdosePain

Related Articles
    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    Unbudgeted: How the Opioid Crisis Is Blowing a Hole in Small-Town America’s Finances

    September 20, 2017

    INDIANA, Pa./CHILLICOTHE, Ohio (Reuters)—As deaths mount in America’s opioid crisis, communities on the front lines face a hidden toll: the financial cost. Ross County, a largely rural region of 77,000 people an hour south of Columbus, Ohio, is wrestling with an explosion in opioid-related deaths—44 last year compared with 19 in 2009. The drug addiction…

    Beyond Addiction: Medical Therapy for Addiction May Benefit Medical Adherence

    June 17, 2019

    Treating patients with rheumatic disease for their addictions will also encourage patients to address their overall health conditions, resulting in better medical adherence…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences